Goserelin does not preserve ovarian function against chemotherapy-induced damage

dc.contributor.author	Oktay, K.
dc.contributor.author	Taylan, E.
dc.contributor.author	Rodriguez-Wallberg, K. A.
dc.contributor.author	Bedoschi, G.
dc.contributor.author	Turan, V.
dc.contributor.author	Pacheco, F.
dc.date.accessioned	2021-12-21T08:47:51Z
dc.date.available	2021-12-21T08:47:51Z
dc.date.issued	2018
dc.identifier.issn	0923-7534
dc.identifier.issn	1569-8041
dc.identifier.uri	https://doi.org/10.1093/annonc/mdx695
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2311
dc.description.sponsorship	NIH (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD053112]; NIH (NCI)United States Department of Health & Huma
dc.language.iso	English
dc.publisher	Oxford Unıv Press
dc.rights	Bronze, Green Published
dc.title	Goserelin does not preserve ovarian function against chemotherapy-induced damage
dc.type	Letter
dc.relation.journal	Annals Of Oncology
dc.identifier.issue	2
dc.identifier.startpage	512
dc.identifier.endpage	513
dc.identifier.volume	29
dc.identifier.doi	10.1093/annonc/mdx695
dc.relation.issue	2
dc.relation.volume	29